Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting
VICTORIA, BC, Nov. 14, 2024 /PRNewswire/ – Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology designed to optimize drug delivery for applicat
Nature’s Miracle Holding Inc. Announces Third Quarter 2024 Financial Results
~ Revenue Growth of 13.5% to $3.1 Million from Q3 2023~ ONTARIO, Calif., Nov. 14, 2024 /PRNewswire/ — Nature’s Miracle Holding Inc. (NASDAQ: NMHI) (“Nature’s Miracle” or the “Company”), a leader in vertical farming technology and infrastructure, today ann
Cabana Partners with Virginia Department of Veterans Services to Provide Comprehensive, Free Mental Health Support for Veterans, Guard/Reserve Members, and Their Families
RICHMOND, Va., Nov. 14, 2024 /PRNewswire/ — Cabana, a modern mental health provider offering confidential, tech-enabled support, has partnered with the Virginia Department of Veterans Services (DVS) to provide free, comprehensive mental health resources to Virginia’s veterans, Guard and
Evofem Biosciences Announces Financial Results for the Third Quarter of 2024
— Improved loss from operations by 31% — — Acquired SOLOSEC, a commercially attractive, single-dose oral antibiotic FDA-approved to treat two pervasive sexual health infections — — Forged commercial agreement for Phexxi in Middle East — SAN DIEGO, Nov. 14, 2024 /PRNewswire/ — Wome
NASA Johnson Invites Proposals to Lease Vibration Test Facility
HOUSTON, Nov. 14, 2024 /PRNewswire/ — NASA’s Johnson Space Center is seeking proposals for the use of its historic, but underused, Vibration and Acoustic Test Facility. Prospective tenants must submit facility walk-through requests by Monday, Nov. 18. Final proposals are due by 12 p.m. E
BrainStorm Cell Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update
Conference call planned for later in Q4 2024 to provide updates on NurOwn® program NEW YORK, Nov. 14, 2024 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results fo
Radiate Holdco, LLC Releases Third Quarter 2024 Financial Results
PRINCETON, N.J., Nov. 14, 2024 /PRNewswire/ — Radiate Holdco, LLC (“Radiate”) announced today that it released its Third Quarter 2024 financial results on its secure investor website. The financial results were provided in accordance with the terms of the Indentures governing Radi
Inhibrx Biosciences Reports Third Quarter 2024 Financial Results
SAN DIEGO, Nov. 14, 2024 /PRNewswire/ — Inhibrx Biosciences, Inc. (Nasdaq: INBX) (“Inhibrx Biosciences” or the “Company”) today reported financial results for the third quarter of 2024. Following the completion of the sale of INBRX-101 by Inhibrx, Inc. (the “Form
SalesRabbit Acquires RoofLink–Creates Incredible Value for Rooftop Sales Teams
LEHI, Utah, Nov. 14, 2024 /PRNewswire/ — SalesRabbit, the leading field sales management platform, announces its acquisition of RoofLink, a robust and efficient CRM solution designed by roofers for roofers. This acquisition represents a significant leap forward for SalesRabbit’s commitme
Plan Your Summer Adventure in Jasper National Park: Camping Reservations open in 2025
Reserve your campsite and explore Jasper’s iconic trails and activities as the park welcomes visitors back to its breathtaking landscapes this summer. JASPER NATIONAL PARK, AB, Nov. 14, 2024 /CNW/ – The Government of Canada is committed to Jasper’s recovery and has put dedicated te
